Gamonet et al., 2020 - Google Patents
Processing methods and storage duration impact extracellular vesicle counts in red blood cell unitsGamonet et al., 2020
View HTML- Document ID
- 2442038028189350826
- Author
- Gamonet C
- Desmarets M
- Mourey G
- Biichle S
- Aupet S
- Laheurte C
- François A
- Resch E
- Bigey F
- Binda D
- Bardiaux L
- Naegelen C
- Marpaux N
- Delettre F
- Saas P
- Morel P
- Tiberghien P
- Lacroix J
- Capellier G
- Vidal C
- Garnache-Ottou F
- Publication year
- Publication venue
- Blood Advances
External Links
Snippet
Extracellular vesicles (EVs) are active components of red blood cell (RBC) concentrates and may be associated with beneficial and adverse effects of transfusion. Elucidating controllable factors associated with EV release in RBC products is thus important to better …
- 210000003743 Erythrocytes 0 title abstract description 125
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gamonet et al. | Processing methods and storage duration impact extracellular vesicle counts in red blood cell units | |
Gallagher et al. | Altered erythrocyte endothelial adherence and membrane phospholipid asymmetry in hereditary hydrocytosis | |
Stroncek et al. | Platelet transfusions | |
Ning et al. | Exploring donor and product factors and their impact on red cell post-transfusion outcomes | |
Wannez et al. | Extracellular vesicles in red blood cell concentrates: an overview | |
Noulsri et al. | Differences in levels of platelet-derived microparticles in platelet components prepared using the platelet rich plasma, buffy coat, and apheresis procedures | |
Alshalani et al. | Biological mechanisms implicated in adverse outcomes of sex mismatched transfusions | |
Hashemi Tayer et al. | Evaluation of blood storage lesions in leuko-depleted red blood cell units | |
Bianchi et al. | Allogeneic cord blood red blood cells: assessing cord blood unit fractionation and validation | |
Plaza et al. | Evaluation of platelet function during extended storage in additive solution, prepared in a new container that allows manual buffy-coat platelet pooling and leucoreduction in the same system | |
Tendulkar et al. | Comparison of plateletpheresis on three continuous flow cell separators | |
Gutensohn et al. | Flow cytometric analysis of platelet membrane antigens during and after continuous‐flow plateletpheresis | |
Masse | Universal leukoreduction of cellular and plasma components: process control and performance of the leukoreduction process | |
Vucic et al. | Evaluation of platelet activation in leukocyte-depleted platelet concentrates during storage | |
Mahmood et al. | Significant reduction in hematological values after plateletpharesis: Clinical implication to the donor | |
Van Der Meer et al. | WBC‐reduced platelet concentrates from pooled buffy coats in additive solution: an evaluation of in vitro and in vivo measures | |
Johnson et al. | Preparation of red blood cell concentrates and plasma units from whole blood held overnight using a hollow‐fibre separation system | |
Philip et al. | Comparative analysis of various aspects of plateletpheresis on the fenwal amicus and Fresenius COM. TEC cell separator instruments | |
Seghatchian et al. | Unresolved clinical aspects and safety hazards of blood derived-EV/MV in stored blood components: from personal memory lanes to newer perspectives on the roles of EV/MV in various biological phenomena | |
Babaahmadi et al. | Comparative evaluation of hematological parameters and instrument performance in single and double plateletpheresis procedures using Haemonetics MCS+ and Trima Accel systems | |
DAS | Haematological Changes in Donors Post Apheresis. | |
Mane et al. | Storage And Stability Of Blood Samples–Changes In The Haematological Values | |
Bhardwaj et al. | Evaluation of quality matrix when practice changed from triple bags to quadruple (top and bottom) bags: In vitro: analysis of blood components! | |
Klaihmon et al. | Internalization of cell-derived microparticles triggers endothelial pro-inflammatory responses | |
Gutensohn et al. | The role of flow cytometry in improving biocompatibility in transfusion medicine |